Expression of the group of cytokines known as transforming growth factor-,f (TGF-pl, -.82 and -p3) is increased during liver regeneration induced by a 70% partial hepatectomy. The origin of these changes was examined in purified isolates of hepatocytes, sinusoidal endothelial cells, Kupffer cells (liver macrophages), and lipocytes (Ito or stellate cells) from normal and regenerating liver. In normal liver, TGF-131 and -132 levels were relatively high in sinusoidal endothelial cells and Kupffer cells. After partial hepatectomy, an early peak of TGF-182 and -,B3 was present in all four cell types, followed by a sustained increase in mRNA for TGF-131, -132, and -133 primarily in the hepatocyte population. The specificity of these changes was established by examining a mechanistically different injury model, fibrosis induced by ligation of the biliary duct. In this model, TGF13 mRNA was increased only in lipocytes and the increase was progressive over a 7-d period of observation. Secretion of TGF13 protein was examined in cell isolates placed in short-term primary culture and generally reflected the corresponding mRNA level. The TGFP released by hepatocytes was entirely in the latent form, whereas the individual nonparenchymal cell isolates released 50-90% active TGF13. Hepatocyte-conditioned culture medium, after treatment to activate latent TGFP, inhibited hepatocellular DNA synthesis as did the authentic factor. The data indicate that after injury TGFI3 increases selectively in the cells that are the target of the factor, i.e., in hepatocytes after partial hepatectomy and in lipocytes in inflammation and fibrosis. We conclude that the effects of TGFP in liver regeneration and fibrogenesis are predominantly, if not exclusively, autocrine. (J. Clin. Invest. 1995. 96:447-455.)
Introduction
The family of TGF/3 comprises three related subtypes, all of which exist in mammals (TGF-,31, -/62, and -/33) (1) . Among the numerous and varied effects attributed to these factors, one of the most prominent is growth inhibition (2) . This has been Thus, it has been proposed that TGFP may be the principal counterregulator of hepatocyte proliferation during regeneration (9) . Important corroborative evidence for this hypothesis is the finding that TGF3 mRNA increases after a 70% partial hepatectomy ( 10, 11 ) . To date, studies of isolated hepatocytes or mixed nonparenchymal cells suggest that the increase in mRNA derives from the latter fraction (perhaps endothelial cells), consistent with a paracrine effect on hepatocytes; it has also been stated that the Pl. form is quantitatively the most important of the TGFP subtypes during regeneration (12) . However, the cellular source(s) of TGFP remains unclear: nonparenchymal isolates are a mixture of sinusoidal endothelial cells, Kupffer cells (liver macrophages), and lipocytes (pericyte-like cells also known as Ito or fat-storing cells). Moreover, a role for hepatocytes is not excluded, given the immunohistological evidence that TGF,6 protein is present in (or on) these cells in the intact liver (12, 13) . Until the question of cellular localization is resolved, the mechanism by which TGFP regulates growth (autocrine or paracrine) in liver regeneration will remain speculative.
The problem is one that requires isolation and quantitative measurement of TGFP gene expression in the individual cell types that constitute a tissue.-an analysis that has not been performed in any epithelium to date, owing in large part to the difficulty in dispersing and purifying the individual cell types that make up a tissue. In liver, however, the methods for this purpose are well developed; moreover, yields are sufficient for direct mRNA analysis without amplification of cell samples in culture. We have used this approach in the current study. Isolates from normal liver or from the regenerating remnant after partial hepatectomy were prepared, and cell-specific expression of TGFP was directly examined, using an RNase protection assay to quantitate mRNA for the three TGFP subtypes. Isolates were also placed in short-term primary culture for evaluating the secretion of TGF,3 protein, both the active form and the latent precursor. To document the specificity of the changes after partial hepatectomy, we performed parallel studies of an injury model in which hepatocyte proliferation is minimal, namely, fibrosis induced by ligation of the biliary duct. The findings indicate, contrary to previous conclusions (12) , that hepatocytes are a major source of TGF,6 during liver regeneration and that they release the latent form. Animals. Young, male Sprague-Dawley rats (200-250-g body weight) or mature animals (-400 g) were used with similar results. Animals were housed under controlled lighting, with chow and water ad libitum, and were subjected to 70% partial hepatectomy or bile duct ligation under ether anesthesia ( 14, 15 ) . Sham-operated animals underwent abdominal incision and tissue manipulation, without ligation of the bile duct or liver lobes. All surgery was performed between 08:00 and 09:00 hours. The abdomen was closed with silk sutures, and the animals were maintained postoperatively on food and water ad libitum.
Liver cell isolation and purification. Hepatocytes were prepared by perfusion of the liver in situ with collagenase and purified by centrifugal elutriation, as previously described (16) . Lipocytes, Kupffer cells, and sinusoidal endothelial cells were isolated separately from liver dispersed with a mixture of collagenase and Pronase; the initial mixture of cells was fractionated on a discontinuous gradient of Larex and further purified by centrifugal elutriation, as described ( 17 ) . Each data point represents the cell isolate from a single rat liver, unless otherwise noted.
Established markers were used to assess the homogeneity of specific cell isolates; these have been described previously and can be summarized as follows. Hepatocytes were identified unambiguously under phase contrast microscopy by their size and distinctive cytologic features (18) ; Kupffer cells were identified by endogenous peroxidase activity, demonstrated histochemically ( 19) . For identifying sinusoidal endothelial cells, human acetoacetylated LDL, prepared with a stable fluorescent lipid, was administered to rats intravenously a few minutes before liver perfusion; within the liver, the lipid accumulates at high concentration only in the sinusoidal endothelium (20) . Isolated endothelial cells were identified by their red fluorescence. Lipocytes were identified by fluorescence microscopy under ultraviolet excitation, which reveals pale blue granules representing the retinoid-containing vacuoles that are characteristic of these cells ( 17) . Biliary epithelial and "oval" cells (from liver subjected to bile duct ligation) were identified histochemically by their content of y-glutamyl transpeptidase (21 assay. Protected fragments were separated on a 5% polyacrylamideurea sequencing gel at 50-550C. Radiolabeled bands were visualized by autoradiography and quantitated by scanning densitometry (Hoefer Scientific, San Francisco, CA). The autoradiographic data were normalized to an internal mRNA, S-14, which encodes a ribosomal protein (24) . The expression of S-14 varies minimally among the cell types of the liver or between normal and injured liver (25) . In a given experiment, assays for TGFP using the different cell extracts were performed and analyzed together.
The amount of RNA in extracts from cells or tissues was monitored spectrophotometrically. In preliminary experiments, it was found that the RNase protection assay was linear for input RNA up to at least 100 jg.
Bioassay of TGF3. The assay was based on a published method (26) , in which TGF/3 is measured by its ability to inhibit proliferation of mink lung epithelial cells. With pure standards (R & D Systems, Inc.), the assay was found to have a working range of 0.1-2.0 pM. Fresh serum-free medium had no effect on the standard curve generated by pure TGF/3. Hepatocyte-conditioned medium contained growth-stimulating activity, as reported previously (11) , causes a shift in the standard curve. The reported values for hepatocytes have been corrected for this effect. For evaluating TGF/3 secretion in culture, the various liver cell isolates were plated and maintained for 2 d under standard conditions (see previously described procedure), washed, and incubated further in serum-free medium. In some experiments, cells were isolated, plated directly in serum-free medium, and incubated for 24 h only. The conditioned medium was harvested, cleared of cells by centrifugation, and assayed for TGF,/. Samples were assayed both with and without prior activation of latent TGF/3. Antibody to TGFfl was added to the sample for assay, at a concentration of 20 Ag/ml for anti-TGF-,/1 and 10 ,g/ml for anti-TGF-/2 or -,/3. Under these conditions, the antibody to TGF-fi1 blocked 70-80% of TGF-f31 activity; the antibodies to TGF-/32 and -,B3 were 100% effective; cross-reactivity was negligible. Control assays with nonimmune IgG were included.
Statistical analysis. Data are presented as mean±SD. Differences have been analyzed by t test for unpaired groups.
Results
TGF13 mRNA in whole-liver extracts after injury. In extracts of normal liver, mRNA for all three TGF3 isoforms was low but detectable by RNase protection assay of 100 isg of total RNA. The levels were essentially unchanged in sham-operated animals at various times points between 2 h and 7 d, except for a transient increase in TGF-#3 mRNA at 2 h to 2.7-fold above the control level (data not shown).
After partial hepatectomy, TGF-/2 and -/33 exhibited a peak at 6 h; by 48 h, TGF-/32 decreased to a plateau approximately two-fold above the control level, and TGF-/33 returned to baseline. The profile of TGF-PlI lacked the early peak, showing instead a rise over 24-48 h to a plateau that was 2.5-fold above control ( Fig. 1 A and Table I ).
With bile duct ligation, little change from control levels occurred for 24 h; then all three TGF,6 mRNAs increased progressively over the entire 7-d period of study ( Fig. 1 B) . TGFJ3 mRNA in cell isolatesfrom normal liver, after partial Table I ). (10) (11) (12) , in which expression of TGFB was localized to mixed nonparenchymal cells.
Cells were also isolated at 6 and 48 h after partial hepatectomy; these time points represent the early peak and the plateau, respectively, of TGF,6 expression in the intact liver (Fig. 1 A) 
Partial Hepatectomy Figure 3 . Changes in TGF/3 mRNAs after partial hepatectomy or bile duct ligation. (A) Partial hepatectomy was performed as in Fig. 1 , and cells were isolated at 6 h (cross-hatched bars) or at 48 h (filled bars), corresponding to the early peak and plateau, respectively, of the whole-liver extracts (Fig. 1 A) . For obtaining sufficient cells from the liver remnant, six animals were used and the cell isolates were combined at each time point. (B) Sham-operated animals. (C) Animals subjected to bile duct ligation, performed as in Fig. 1 . All extracts were probed for S-14 mRNA (data not shown). The autoradiographic data were quantitated and corrected as in Fig. 1 . The data are presented as the change in mRNA expression, relative to normal, unoperated controls (Fig. 2) . The entire experiment was performed twice, with similar results. H, hepatocytes; L, lipocytes; E, endothelial cells; K, Kupffer cells.
-/32, seen in the whole-liver extracts (Fig. 1 A) , derives largely by ligation of the biliary duct, which involves inflammation from hepatocytes, given that hepatocytes represent 65% of the and fibrosis but minimal hepatocyte proliferation. Cell-specific cells and 90% of the volume of the liver (27) . In the case expression of the TGF/3s was measured 7 d after the procedure, of the mRNA for TGF-/33, though all four cell populations when changes in whole-liver extracts were maximal (Fig. 1 B) . contributed to the early peak, Kupffer cells predominated. By
In contrast to the findings in the regeneration model, the increase 48 h, all cells except hepatocytes exhibited reduced levels. in TGF,6 was limited to lipocytes, among the four cell types
In parallel studies, we also evaluated liver injury induced examined (Fig. 3 C) . Because proliferation of biliary epithelial Time (hr) Figure 4 . TGF/3 mRNAs in hepatocyte isolates during liver regeneration. At the indicated time points after a 70% partial hepatectomy, hepatocytes were isolated, purified by centrifugal elutriation, and extracted for mRNA measurement (see Methods). The resulting autoradiographic data were quantitated and corrected as for Fig. 1 Finding that the changes in all three TGFf3s after partial hepatectomy involved hepatocytes, we performed a detailed study of this cell type (Fig. 4) . The time course of expression for each subtype of TGFP3 resembled that for the whole-liver extracts ( Fig. 1 A) Table II . At 6 h after partial hepatectomy, TGF-,l3 was predominant, reflecting the mRNA profile at this time point (Fig. 4) ; at 48 h, the three isoforms were secreted at similar levels. Over a longer period of culture (up to 6 d), release of TGF,3 by hepatocytes increased progressively, whereas that by individual nonparenchymal cell types either was flat or fell slightly (Fig. 5) . The material produced by long-term hepato- cyte cultures continued to be latent, but there was a shift in subtype to the /32 isoform only. The localization of this form in hepatocyte culture was examined and found to be pericellular (Fig. 6 ). The proportion of active material produced by the nonparenchymal cells did not change significantly with time in culture (Fig. 5) .
Finally, the bioactivity of TGF,3 was examined with fresh hepatocytes exposed to hepatocyte-conditioned medium. The medium was treated to activate latent TGF,/; controls included cells incubated with authentic TGF-,82. As shown (Table III) , the activated conditioned medium, containing an estimated 50 pg/ml TGF-/32 ( Fig. 5) , completely suppressed replicative DNA synthesis in cultured hepatocytes.
Discussion
This is the first quantitative study of TGFB expression by the principal cell populations of the liver and its modulation by injury. A salient finding is the increased expression of this factor by hepatocytes after partial hepatectomy (Table IV) . Although previously published immunohistological studies had shown TGF/3 protein in hepatocytes (12, 13) , the mRNA was detectable solely in nonparenchymal cells ( 12, 28, 29 (Fig. 3) . Most of this, however, contributes only to the early peak of TGFP mRNA from wholeliver extracts (Fig. 2) . The significance of the early peak is unclear; it occurs before the onset of DNA synthesis and may play a role in the timing of cell division. With regard to the later peak (at 48 h), only lipocytes, other than hepatocytes, exhibit an elevation of TGFB mRNA (Fig. 3) . Regeneration entails restitution not only of cell mass, but also of extracellular matrix (31) . One may speculate that the increase in TGF-f32 in lipocytes is related to this process, as lipocytes are the principal source of extracellular matrix in normal liver (23) .
TGFP figures prominently in two distinct and very different types of liver injury: (a) in partial hepatectomy, in which it is implicated in downregulating hepatocyte proliferation stimulated by the injury (3-8) ; and (b) in inflammation, in which it stimulates production of extracellular matrix by lipocytes ( 13, 28, 29, 32) . Interestingly, although the effects of TGFJ3 are protean, in these injury models they appear to be highly selec- (31) . The present data address, at least indirectly, the basis for selective effects of TGFJ3 in these two contrasting scenarios. TGF/3 is subject potentially to several different kinds of regulation, both intra-and extracellularly (33) . First, at the level of the protein, the conversion of latent precursor to active factor represents a potential point of regulation. In vitro and in cell culture, this is accomplished with proteolysis, possibly mediated by plasmin (34) , which itself is subject to multilevel controls (35) . Whether plasmin or other proteases serve this function in vivo is speculative. Beyond the activation step, TGF,3 receptor expression may govern the effect of TGFP3 at the cellular level. Of interest in this regard is the finding that receptors on lipocytes appear to increase in hepatic fibrogenesis, according to studies with a cell culture model of fibrogenesis (36) . Finally, as indicated by the current data, the effect of TGFP in vivo may be linked to its cellular site of secretion.
For the injury models studied, the cell type in which expression of TGF,3 is increased is also the apparent target of the factor (hepatocytes and lipocytes in regeneration and inflammation, respectively). From this, we propose that TGF,3 is predomi- (Fig. 3) . This is in agreement with a previous study using in situ hybridization, in which the isoform appeared to be TGF-/31 (32) . As in the regenerating liver, expression by Kupffer cells and sinusoidal endothelial cells is unchanged (Fig. 3) (32) . In other tissues also, expression of this isoform is increased selectively in proliferating epithelium. For example, TGF-/32 mRNA is minimal in the virgin mammary gland of the mouse. However, it increases strikingly during pregnancy, when proliferation of the glandular epithelium is prominent; with the onset lactation, it rapidly subsides (42) . Another example is the rat intestine, in which renewal of the mucosal epithelium is continuous in the normal state: over a period of -30 h, epithelial cells migrate from the villus crypt to the tip and then slough into the intestinal lumen.
In this setting of proliferation, it was found that the /32 subtype was the only form of TGF3 detectable (43). Also, in the mouse embryo, expression of TGF-,62 is notably prominent in the developing foregut (44) , which is consistent with a role in the proliferative phase of epithelial morphogenesis. Interestingly, in the current studies, it was found that beyond 3 d of primary culture, hepatocellular production of TGF/3 increased notably and was essentially 100% TGF-/2. Cells at this stage of culture exhibit several "fetal" markers (45, 46) . Extrapolating to the regenerating liver, one may speculate that the /32 subtype is associated with immature hepatocytes, possibly related to stem cells (47) .
A recent addition to the list of potential growth regulators in the liver is activin, which has been implicated in apoptosis of hepatocytes (48) and is a negative regulator of hepatocyte proliferation (49) . Activin belongs to the TGF/3 superfamily but has limited homology with TGF/3 itself (-33% at the amino acid level), and its biological effects in general differ from those of TGF,/ (50) . With regard to the liver, it uses distinct receptors (on hepatocytes) (48) and, as an apoptotic factor, is 10-fold less potent than TGF/3 (48) . It differs from TGF,/ also in being secreted as the active peptide rather than in latent form, and its secretion by hepatocytes occurs only in the presence of a mitogen such as EGF. Also, it has no activity in the mink lung cell assay (Schwall, R., personal communication). Thus, activin and TGF/3 are distinct and separable factors, despite their apparently similar effects on hepatocytes in culture.
The fact that TGFP is released by hepatocytes almost entirely as the latent factor raises the question of where and how it undergoes activation. If a proteinase such as plasmin (34) is required, activation of TGF/3 released by hepatocytes could require both sinusoidal endothelial cells and lipocytes, in what might be described as a modified autocrine process. On the other hand, activation of TGF/3 may occur on the hepatocyte surface, presumably via a membrane-associated proteinase, providing further support for the autocrine hypothesis. In fact, a recent study suggests that hepatocytes from regenerating liver (but not normal liver) are capable of activating latent TGF/3 (12) .
In summary, we propose that modulation of TGF/ in liver injury is isoform and cell specific and moreover that the selective effects of the factor in a given type of injury are due predominantly, if not exclusively, to an autocrine mode of action.
